Physician profile
Michael S Weinstein
NPI 1437119211
$17,577.71
in general payments reported to CMS, 2019-2025
47 companies · $4,166 in 2025
The $4,166 reported for 2025 was more than what 92% of Sleep Medicine (Internal Medicine) providers received nationally (typical 2025 total: $447).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $772 · 2020: $486 · 2021: $830 · 2022: $2,428 · 2023: $4,832 · 2024: $4,064 · 2025: $4,166.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $13K · Education: $264.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $12,798.35 |
| Education | $263.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $3,935.33 | 2019-2025 | Fasenra, Airsupra, Breztri |
| Glaxosmithkline, LLC. | $3,118.57 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Jazz Pharmaceuticals INC. | $1,362.60 | 2019-2025 | |
| Harmony Biosciences LLC | $1,268.86 | 2021-2025 | Wakix |
| Axsome Therapeutics, INC. | $1,055.40 | 2022-2025 | Sunosi |
| Genzyme Corporation | $636.44 | 2021-2025 | |
| Mallinckrodt Hospital Products INC. | $612.31 | 2020-2025 | Acthar |
| Boehringer Ingelheim Pharmaceuticals, INC. | $608.56 | 2019-2025 | Stiolto Respimat, Spiriva Respimat, Ofev |
| Regeneron Healthcare Solutions, INC. | $559.85 | 2019-2025 | Dupixent |
| Baxter Healthcare | $394.02 | 2022-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System, Hillrom - Volara System |
| Mylan Specialty L.P. | $374.78 | 2019-2024 | Yupelri |
| Insmed, INC. | $356.37 | 2019-2025 | Arikayce, Brinsupri |
| Zoll Respicardia, INC. | $340.26 | 2023 | Remede System |
| Philips North America LLC | $313.15 | 2019-2025 | Vest Therapy Und, (Ak6) Vest Therapy |
| Amgen INC. | $283.90 | 2022-2024 | Tezspire, Tavneos |
Show all 47 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avadel Cns Pharmaceuticals, LLC | $225.72 | 2023-2024 | Lumryz |
| Verona Pharma, INC. | $211.49 | 2025 | Ohtuvayre |
| Sanofi-Aventis U.S. LLC | $189.94 | 2025 | |
| Ani Pharmaceuticals, INC. | $181.75 | 2022-2025 | Purified Cortrophin Gel |
| Genentech USA, INC. | $179.88 | 2019-2025 | Xolair |
| Inspire Medical Systems, INC. | $154.43 | 2023-2025 | Inspire |
| Electromed, INC. | $140.96 | 2023-2025 | Smartvest |
| Takeda Pharmaceuticals U.S.A., INC. | $139.78 | 2022-2025 | Aralast, Cuvitru |
| Pulmonx Corporation | $115.34 | 2025 | Chartis Catheter, Zephyr Endobronchial Valve, Zephyr Delivery Catheter |
| Pfizer INC. | $111.84 | 2020-2024 | |
| Grifols USA, LLC | $90.48 | 2019-2023 | Prolastin-C Liquid |
| Novartis Pharmaceuticals Corporation | $77.71 | 2019-2024 | |
| United Therapeutics Corporation | $57.48 | 2021-2024 | Tyvaso |
| Advanced Respiratory, INC | $45.87 | 2021 | |
| Sunovion Pharmaceuticals INC. | $38.66 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $37.69 | 2022-2023 | Airduo Digihaler |
| Lilly USA, LLC | $36.95 | 2025 | Zepbound |
| Paratek Pharmaceuticals, INC. | $35.19 | 2023 | Nuzyra |
| Merck Sharp & Dohme LLC | $29.39 | 2019-2023 | |
| Alexion Pharmaceuticals, INC. | $28.29 | 2024 | Ultomiris |
| Abbvie INC. | $26.61 | 2022 | |
| Daiichi Sankyo INC. | $24.51 | 2024 | Enhertu |
| Vifor Pharma, INC. | $22.36 | 2025 | Zemaira |
| Idorsia Pharmaceuticals US INC | $21.67 | 2023 | Quviviq |
| Viatris Specialty LLC | $19.22 | 2025 | Yupelri |
| Resmed Corp | $18.65 | 2023 | |
| Mallinckrodt Enterprises LLC | $18.49 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.11 | 2019 | |
| Shire North American Group INC | $16.27 | 2019 | |
| Allergan, INC. | $15.80 | 2019 | |
| Optinose US, INC. | $14.32 | 2022 | |
| Circassia INC. | $12.46 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Weinstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.